A collaborative research effort led by Daan van der Vliet and a multidisciplinary team from the Netherlands Institute for Neuroscience,…
Read More
Salk Institute Researchers Identify Protein BCL6 as Key Regulator for Preventing Muscle Loss During Weight Management and Disease
The rapid rise of glucagon-receptor agonists (GLP-1) has transformed the landscape of metabolic health, offering unprecedented results for individuals struggling…
Read More
Long-Term Chlorpyrifos Exposure Linked to 2.5-Fold Increase in Parkinson’s Disease Risk UCLA Researchers Find
A groundbreaking study led by researchers at UCLA Health has established a definitive link between long-term residential exposure to the…
Read More
Scientists Identify Karyoptosis as a Key Mechanism of Neurodegeneration in Alzheimer’s Disease and Frontotemporal Dementia
In a landmark study that could redefine the scientific understanding of neurodegenerative progression, researchers have identified a previously unknown biological…
Read More
Study Reveals Artery Widening Not Fatty Plaque as Primary Driver of Lacunar Stroke and Small Vessel Disease
The medical community is facing a significant paradigm shift in its understanding of cerebrovascular health as new research challenges long-held…
Read More
Pioneering Immune-Based Therapies: How NK Cell-Derived Extracellular Vesicles Offer New Hope for Traumatic Brain Injury and Alzheimer’s Disease
Traumatic brain injury (TBI) stands as a formidable global health crisis, impacting an estimated 69 million individuals each year with…
Read More
Ipsen Acquires Rare Disease Specialist Memo Therapeutics for up to €700 Million, Bolstering Pipeline with Promising BK Polyomavirus Asset
Paris, France – In a significant strategic move to expand its rare disease portfolio, global biopharmaceutical company Ipsen announced today…
Read More
Sanofi’s Nexviazyme Demonstrates Promising Results in Infants with Infantile-Onset Pompe Disease, Paving Way for Potential Label Expansion
Sanofi’s groundbreaking treatment for Pompe disease, Nexviazyme (avalglucosidase alfa), has achieved a significant milestone with the successful completion of the…
Read More
How CTF is trying to rescue pharma’s shelved rare disease drugs
More than 5,000 potentially life-changing treatments for rare diseases are currently languishing on the shelves of pharmaceutical companies, dormant and…
Read More
The Genetic Legacy of Paternal Aging: How Intra-Testicular Selection Drives Disease-Causing Mutations in Sperm
The biological clock has long been a central theme in discussions regarding maternal health and fertility, but a landmark pair…
Read More
